HTG Molecular Diagnostics, Inc. Deferred Costs, Noncurrent
HTG Molecular Diagnostics, Inc. had Deferred Costs, Noncurrent of $198.09 thousand as of 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2019-08-06
- 2019-06-30: Deferred Costs, Noncurrent $198.09K.
- 2019-03-31: Deferred Costs, Noncurrent $198.09K.
- 2018-12-31: Deferred Costs, Noncurrent $59.03K.
- 2017-12-31: Deferred Costs, Noncurrent $2.95K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2019-06-30 | $198.09K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $198.09K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $59.03K 10-Q · filed 2019-08-06 |
| 2017-12-31 | $2.95K 10-K · filed 2019-03-07 |
| 2017-03-31 | $115.06K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $49.63K 10-K · filed 2018-03-23 |
| 2015-12-31 | $52.38K 10-K · filed 2016-03-25 |
| 2015-09-30 | $59.58K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $64.11K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $1.74M 10-Q · filed 2015-06-08 |
| 2014-12-31 | $1.37M 10-K · filed 2016-03-25 |